Colgate-Palmolive (NYSE:CL) Shares Bought by Versant Capital Management Inc

Versant Capital Management Inc raised its holdings in Colgate-Palmolive (NYSE:CL) by 32.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,881 shares of the company’s stock after purchasing an additional 465 shares during the period. Versant Capital Management Inc’s holdings in Colgate-Palmolive were worth $171,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at $53,000. Prospera Private Wealth LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth about $64,000. True Wealth Design LLC raised its stake in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC lifted its holdings in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CL. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. TD Cowen lowered their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $90.15 on Friday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a one year low of $79.52 and a one year high of $109.30. The stock’s 50 day moving average price is $93.46 and its 200 day moving average price is $98.46. The firm has a market capitalization of $73.65 billion, a PE ratio of 25.83, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.